Clinic
Lakewood Resource and Referral Center, INC.
Lakewood Resource and Referral Center, INC. was paid $8.14M by Medicaid between Jan 2018 and Nov 2024, across 52 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 69% of everything it billed.
33Billing provider infoLAKEWOOD RESOURCE AND REFERRAL CENTER, INC.
LAKEWOOD, NJ 08701
LAKEWOOD, NJ 08701
33aNPI1558816520assigned 08/19/2016
33bProvider typeFederally Qualified Health Center (FQHC)
28Total paid$8.14M
24GClaims344,856
24DCodes billed52
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Federally Qualified Health Center (FQHC) providers in New Jersey
Rank by total paid#9 of 98
Median peer was paid$758K
This provider vs. median11×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official FRIEDMAN, DAVID controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 46,768 | $1.18M | |
| 2019 | 43,151 | $1.15M | |
| 2020 | 39,933 | $995K | |
| 2021 | 61,169 | $1.52M | |
| 2022 | 55,299 | $1.19M | |
| 2023 | 58,323 | $1.27M | |
| 2024incomplete | 40,213 | $828K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 69% | 168,873 | 158,120 | $5.63M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 6.3% | 9,240 | 9,211 | $514K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 6.3% | 81,811 | 79,197 | $511K |
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 5.5% | 18,236 | 17,075 | $445K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.7% | 12,338 | 11,956 | $300K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.6% | 22,321 | 11,095 | $210K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.5% | 3,170 | 3,071 | $121K |
| 87428 | <1% | 1,140 | 1,109 | $61K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 1,811 | 1,767 | $42K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 495 | 478 | $37K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 1,291 | 1,288 | $35K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 639 | 636 | $31K |
40 more codes
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 621 | $27K |
| 87081 | <1% | 7,325 | $23K | |
| 0001A | <1% | 491 | $19K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 496 | $19K |
| 0011A | <1% | 592 | $19K | |
| 0012A | <1% | 516 | $19K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 44 | $18K |
| 0002A | <1% | 431 | $17K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 495 | $12K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 191 | $9K |
| 90686 | <1% | 554 | $4K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 356 | $4K |
| 0064A | <1% | 73 | $3K | |
| 0031A | <1% | 60 | $2K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 23 | $1K |
| 90670 | <1% | 125 | $1K | |
| 0004A | <1% | 16 | $640.00 | |
| 0071A | <1% | 16 | $640.00 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 23 | $575.18 |
| 0072A | <1% | 14 | $560.00 | |
| 90734 | <1% | 12 | $372.18 | |
| 90656 | <1% | 19 | $289.71 | |
| 94760 | <1% | 103 | $265.40 | |
| 99173 | <1% | 110 | $140.75 | |
| 81003 | <1% | 149 | $94.51 | |
| 90680 | <1% | 14 | $90.50 | |
| 91306 | <1% | 50 | $49.00 | |
| 91301 | <1% | 62 | $45.00 | |
| Q0244 | Injection, casirivimab and imdevimab, 1200 mg | <1% | 43 | $40.00 |
| 91300 | <1% | 181 | $7.00 | |
| 3079F | 0% | 845 | $0.00 | |
| 3074F | 0% | 4,984 | $0.00 | |
| 90677 | 0% | 15 | $0.00 | |
| 3075F | 0% | 88 | $0.00 | |
| 91307 | 0% | 24 | $0.00 | |
| 90697 | 0% | 14 | $0.00 | |
| 3078F | 0% | 4,232 | $0.00 | |
| 90633 | 0% | 12 | $0.00 | |
| 3077F | 0% | 12 | $0.00 | |
| 0502F | 0% | 60 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFRIEDMAN, DAVID (CEO)
| Provider | Location | Paid |
|---|---|---|
| Lakewood Resource and Referral Center INC | Lakewood, NJ | $46.70M |
| Hospice Cheer | Pasadena, CA | $5.77M |
| Lakewood Resource and Referral Center INC | Lakewood, NJ | $2.37M |
| Eastland Subacute and Rehab LLC | El Monte, CA | $2.23M |
| Chino Valley Rehabilitation Center LLC | Pomona, CA | $1.21M |
| Colonial Care Center INC. | Long Beach, CA | $884K |
| SGV Healthcare INC | San Gabriel, CA | $698K |
| Artesia Healthcare, INC | Burbank, CA | $642K |
| Ability Homecare, INC | Sherman Oaks, CA | $213K |
| Comfort Care Hospice, INC. | Sherman Oaks, CA | $200K |
| Park Anaheim Health Care, LLC | Anaheim, CA | $147K |
| Coldwater Care Center LLC | N Hollywood, CA | $75K |
| Imperial Crest Healthcare Center, LLC | Hawthorne, CA | $47K |
| David B. Friedman, MD, INC | Anaheim, CA | $42K |
| Covina Care Center, INC. | Covina, CA | $21K |
| Cerritos Vista Healthcare Center LLC | Bellflower, CA | $19K |
| Mayflower Care Center LLC | El Monte, CA | $19K |
| Montrose Healthcare INC | Montrose, CA | $9K |
| Meadows Ridge Care Center LLC | Colton, CA | $8K |
| Beaumont Manor LLC | Beaumont, CA | $1K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.